Global Botulinum Toxin Market, By Type B
| Label | Chronic Migraine | Spasticity | Cervical Dystonia | Overactive Bladder | Blepharospasm | Others |
|---|---|---|---|---|---|---|
| 2016 | 626.77 USD Mn | 506.34 USD Mn | 383.1 USD Mn | 231.44 USD Mn | 190.28 USD Mn | 211.13 USD Mn |
| 2017 | 699.74 USD Mn | 564.75 USD Mn | 427.74 USD Mn | 257.88 USD Mn | 207.42 USD Mn | 234.67 USD Mn |
| 2018 | 782.06 USD Mn | 629.95 USD Mn | 477.63 USD Mn | 287.36 USD Mn | 225.23 USD Mn | 260.85 USD Mn |
| 2019 | 863.86 USD Mn | 694.47 USD Mn | 527.11 USD Mn | 316.48 USD Mn | 241.54 USD Mn | 286.57 USD Mn |
| 2020 | 955.07 USD Mn | 765.54 USD Mn | 581.68 USD Mn | 348.87 USD Mn | 260.41 USD Mn | 315.11 USD Mn |
| 2021 | 1054.95 USD Mn | 843.1 USD Mn | 641.3 USD Mn | 383.45 USD Mn | 281.13 USD Mn | 346.17 USD Mn |
| 2022 | 1167.36 USD Mn | 930.2 USD Mn | 708.31 USD Mn | 422.21 USD Mn | 304.1 USD Mn | 380.8 USD Mn |
| 2023 | 1289.43 USD Mn | 1024.44 USD Mn | 780.91 USD Mn | 464.05 USD Mn | 328.2 USD Mn | 418.12 USD Mn |
| 2024 | 1424.89 USD Mn | 1128.73 USD Mn | 861.33 USD Mn | 511.29 USD Mn | 353.18 USD Mn | 459.31 USD Mn |
| 2025 | 1573.87 USD Mn | 1243.07 USD Mn | 950.55 USD Mn | 563.09 USD Mn | 378.7 USD Mn | 504.33 USD Mn |
Data Source: Wantstats Repository
Market Dynamics
Of the 6 groups compared here, Chronic Migraine is out front by 2025 at 1.57B USD — 30% of the group total.
Second place: Spasticity, 1.24B USD, trailing Chronic Migraine by 21%.
Chronic Migraine grows to 1.57B USD by 2025, from 626.77M USD in 2016 — 151% up.
Spasticity: 506.34M USD in 2016 to 1.24B USD by 2025, up 146%.
Cervical Dystonia climbs from 383.10M USD (2016) to 950.55M USD (2025), a 148% gain.
Overactive Bladder: up 143% over the period, 231.44M USD to 563.09M USD.
Others: 211.13M USD to 504.33M USD, 139% higher by 2025.
Blepharospasm: 190.28M USD to 378.70M USD, 99% higher by 2025.
The 6-group total: 2.15B USD in 2016, 5.21B USD by 2025, 143% overall.
Making Sense Of 6 Series At Once
There are 6 separate series stacked into this one chart. Look at relative size and relative movement, not just whichever line sits highest.
The largest series today is not guaranteed to stay largest — check the growth rate of each group, not just its current size, before projecting the ranking forward.
The most practical way to read this is relative: set the Global Botulinum Toxin market figures beside other regions or segments of the same market to see where growth is concentrated.
Figures before the 2018 base year are historical estimates; the years through 2025 are projections built from industry data, company revenues, and primary interviews. Forecasts are revised as new data comes in, so check the full report for the latest assumptions.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Charts From Same Market
View AllGlobal Botulinum Toxin Market, By Type A
Global Botulinum Toxin Market, By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



